GSG1
gene geneOn this page
Also known as MGC3146
Summary
GSG1 (germ cell associated 1, HGNC:19716) is a protein-coding gene on chromosome 12p13.1, encoding Germ cell-specific gene 1 protein (Q2KHT4). May cause the redistribution of PAPOLB from the cytosol to the endoplasmic reticulum.
Predicted to enable RNA polymerase binding activity. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in plasma membrane.
Source: NCBI Gene 83445 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 69 total
- MANE Select transcript:
NM_001080555
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19716 |
| Approved symbol | GSG1 |
| Name | germ cell associated 1 |
| Location | 12p13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC3146 |
| Ensembl gene | ENSG00000111305 |
| Ensembl biotype | protein_coding |
| Entrez | 83445 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 10 protein_coding
ENST00000337630, ENST00000351606, ENST00000396302, ENST00000432710, ENST00000457134, ENST00000537302, ENST00000542415, ENST00000545401, ENST00000545699, ENST00000651961
RefSeq mRNA: 15 — MANE Select: NM_001080555
NM_001080554, NM_001080555, NM_001206842, NM_001206843, NM_001206845, NM_001367358, NM_001367359, NM_001367360, NM_001367361, NM_001367362, NM_001367363, NM_001367364, NM_001368007, NM_031289, NM_153823
CCDS: CCDS44835, CCDS44836, CCDS55806, CCDS55807, CCDS55808, CCDS8659, CCDS91657
Canonical transcript exons
ENST00000651961 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001095868 | 13089208 | 13089276 |
| ENSE00001299582 | 13088862 | 13088909 |
| ENSE00001683055 | 13103465 | 13103667 |
| ENSE00001839096 | 13083532 | 13085243 |
| ENSE00003471732 | 13090503 | 13090818 |
| ENSE00003520474 | 13087152 | 13087263 |
| ENSE00003674036 | 13087907 | 13088059 |
Expression profiles
Bgee: expression breadth ubiquitous, 143 present calls, max score 98.82.
FANTOM5 (CAGE): breadth broad, TPM avg 2.9408 / max 1109.2139, expressed in 207 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 129780 | 1.0729 | 87 |
| 129786 | 0.6848 | 41 |
| 129779 | 0.5952 | 61 |
| 129787 | 0.4780 | 7 |
| 129781 | 0.0538 | 6 |
| 129785 | 0.0340 | 17 |
| 129782 | 0.0221 | 6 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 98.82 | gold quality |
| right testis | UBERON:0004534 | 98.67 | gold quality |
| sperm | CL:0000019 | 98.45 | gold quality |
| male germ cell | CL:0000015 | 96.43 | gold quality |
| adult organism | UBERON:0007023 | 96.00 | gold quality |
| testis | UBERON:0000473 | 95.39 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.00 | gold quality |
| body of pancreas | UBERON:0001150 | 69.95 | gold quality |
| pancreas | UBERON:0001264 | 62.02 | gold quality |
| prefrontal cortex | UBERON:0000451 | 61.59 | gold quality |
| stromal cell of endometrium | CL:0002255 | 60.55 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 57.35 | gold quality |
| cingulate cortex | UBERON:0003027 | 57.33 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 56.96 | gold quality |
| jejunal mucosa | UBERON:0000399 | 56.40 | gold quality |
| metanephros cortex | UBERON:0010533 | 56.38 | gold quality |
| frontal cortex | UBERON:0001870 | 55.72 | gold quality |
| neocortex | UBERON:0001950 | 55.54 | gold quality |
| cortical plate | UBERON:0005343 | 55.45 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 55.25 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 55.15 | silver quality |
| right frontal lobe | UBERON:0002810 | 54.93 | gold quality |
| cerebral cortex | UBERON:0000956 | 53.40 | gold quality |
| duodenum | UBERON:0002114 | 52.29 | gold quality |
| metanephros | UBERON:0000081 | 52.07 | gold quality |
| cortex of kidney | UBERON:0001225 | 51.54 | gold quality |
| telencephalon | UBERON:0001893 | 51.37 | gold quality |
| hypothalamus | UBERON:0001898 | 50.70 | gold quality |
| forebrain | UBERON:0001890 | 50.22 | gold quality |
| nucleus accumbens | UBERON:0001882 | 50.16 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | yes | 1278.68 |
| E-MTAB-11121 | yes | 624.95 |
| E-GEOD-134144 | yes | 32.98 |
| E-MTAB-7249 | no | 15.29 |
| E-ANND-3 | no | 3.40 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): ESR1
miRNA regulators (miRDB)
77 targeting GSG1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-4713-3P | 100.00 | 65.92 | 505 |
| HSA-MIR-371A-3P | 99.99 | 66.77 | 91 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-6499-3P | 99.90 | 66.38 | 1212 |
| HSA-MIR-15A-5P | 99.90 | 72.80 | 2787 |
| HSA-MIR-15B-5P | 99.90 | 72.78 | 2798 |
| HSA-MIR-16-5P | 99.90 | 72.80 | 2780 |
| HSA-MIR-195-5P | 99.90 | 72.81 | 2805 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-34B-5P | 99.78 | 67.56 | 1175 |
| HSA-MIR-449C-5P | 99.78 | 67.63 | 1168 |
| HSA-MIR-2682-5P | 99.73 | 67.38 | 1055 |
| HSA-MIR-5580-3P | 99.70 | 69.41 | 2052 |
| HSA-MIR-12124 | 99.68 | 69.17 | 2700 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
| HSA-MIR-1260A | 99.61 | 66.67 | 1098 |
| HSA-MIR-1260B | 99.61 | 66.67 | 1098 |
| HSA-MIR-4524A-5P | 99.57 | 71.73 | 1193 |
| HSA-MIR-4524B-5P | 99.57 | 71.68 | 1195 |
| HSA-MIR-3915 | 99.45 | 68.49 | 1905 |
| HSA-MIR-889-5P | 99.41 | 68.75 | 1025 |
| HSA-MIR-7515 | 99.31 | 68.22 | 1795 |
| HSA-MIR-148A-5P | 99.30 | 68.27 | 1141 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gsg1 | ENSMUSG00000030206 |
| rattus_norvegicus | Gsg1 | ENSRNOG00000008518 |
Paralogs (10): LIM2 (ENSG00000105370), NKG7 (ENSG00000105374), PMP22 (ENSG00000109099), EMP1 (ENSG00000134531), EMP3 (ENSG00000142227), CLDND2 (ENSG00000160318), GSG1L (ENSG00000169181), TMEM202 (ENSG00000187806), EMP2 (ENSG00000213853), GSG1L2 (ENSG00000214978)
Protein
Protein identifiers
Germ cell-specific gene 1 protein — Q2KHT4 (reviewed: Q2KHT4)
All UniProt accessions (8): A0A494C0G6, Q2KHT4, F1T0A0, F1T0A1, F5GYH0, F5H0V9, F5H134, G3XAB9
UniProt curated annotations — full annotation on UniProt →
Function. May cause the redistribution of PAPOLB from the cytosol to the endoplasmic reticulum.
Subunit / interactions. Interacts with PAPOLB.
Subcellular location. Endoplasmic reticulum membrane.
Similarity. Belongs to the GSG1 family.
Isoforms (8)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q2KHT4-1 | 1 | yes |
| Q2KHT4-2 | 2 | |
| Q2KHT4-3 | 3 | |
| Q2KHT4-4 | 4 | |
| Q2KHT4-5 | 5 | |
| Q2KHT4-6 | 6 | |
| Q2KHT4-7 | 7 | |
| Q2KHT4-8 | 8 |
RefSeq proteins (15): NP_001074023, NP_001074024, NP_001193771, NP_001193772, NP_001193774, NP_001354287, NP_001354288, NP_001354289, NP_001354290, NP_001354291, NP_001354292, NP_001354293, NP_001354936, NP_112579, NP_722545 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012478 | GSG-1 | Family |
| IPR050579 | PMP-22/EMP/MP20-like | Family |
Pfam: PF07803
UniProt features (15 total): splice variant 6, transmembrane region 4, sequence variant 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2KHT4-F1 | 70.79 | 0.35 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 77 (showing top):
LI_CISPLATIN_RESISTANCE_DN, KORKOLA_CHORIOCARCINOMA_DN, SENESE_HDAC1_AND_HDAC2_TARGETS_DN, KORKOLA_EMBRYONAL_CARCINOMA_DN, GNF2_CCNA1, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, SENESE_HDAC3_TARGETS_DN, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOCC_ORGANELLE_SUBCOMPARTMENT, WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR, WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D, ATF2_S_UP.V1_UP, PRC2_EED_DN.V1_UP, ALK_DN.V1_DN, KRAS.BREAST_UP.V1_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): endoplasmic reticulum membrane (GO:0005789), plasma membrane (GO:0005886), endoplasmic reticulum (GO:0005783), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
354 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GSG1 | RIMKLB | Q9ULI2 | 491 |
| GSG1 | SCAPER | Q9BY12 | 477 |
| GSG1 | TMEM39B | Q9GZU3 | 392 |
| GSG1 | OR6A2 | O95222 | 369 |
| GSG1 | CASKIN2 | Q8WXE0 | 348 |
| GSG1 | VWC2 | Q2TAL6 | 335 |
| GSG1 | PRRT1 | Q99946 | 330 |
| GSG1 | PPP2R5B | Q15173 | 317 |
| GSG1 | SLF2 | Q8IX21 | 316 |
| GSG1 | SH3BGR | P55822 | 300 |
| GSG1 | RHEBL1 | Q8TAI7 | 288 |
| GSG1 | FAM124B | Q9H5Z6 | 288 |
| GSG1 | NRN1 | Q9NPD7 | 284 |
| GSG1 | SIGLEC11 | Q96RL6 | 282 |
| GSG1 | TSSK2 | Q96PF2 | 281 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRAF2 | GSG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GSG1 | TRAF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GSG1 | IL37 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (14): GSG1 (Two-hybrid), ASAH1 (Affinity Capture-MS), IL37 (Affinity Capture-MS), IL37 (Affinity Capture-MS), ASAH1 (Affinity Capture-MS), GSG1 (Two-hybrid), ARFIP2 (Two-hybrid), FTHL17 (Two-hybrid), SDCBP (Two-hybrid), SYT16 (Two-hybrid), PITPNC1 (Two-hybrid), MIEF2 (Two-hybrid), IL37 (Affinity Capture-MS), GSG1 (Protein-peptide)
ESM2 similar proteins: A0A494BZU4, A0A7H0DND7, A0JNG0, A2T345, A4IIV4, C4QM85, E7F594, G5EDX4, O02051, O45306, P0DP42, P0DST5, P0DST6, P21061, P24763, P34362, P34363, P53053, Q09282, Q0II41, Q10907, Q11071, Q11085, Q13571, Q20249, Q297K8, Q2KHT4, Q2KJA5, Q32KQ5, Q5DC12, Q5GH77, Q5PQM0, Q5RD28, Q5REZ0, Q5TAH2, Q61168, Q6AXT9, Q6GV27, Q6GV28, Q7K1V5
Diamond homologs: A4IIV4, A8MUP6, D3Z7H4, D3ZK93, Q2KHT4, Q3SZT1, Q4V922, Q6AYL2, Q6UXU4, Q8R1W2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
69 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 49 |
| Likely benign | 13 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1002 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:13085239:CCATG:C | acceptor_gain | 1.0000 |
| 12:13085240:CATG:C | acceptor_gain | 1.0000 |
| 12:13085240:CATGC:C | acceptor_gain | 1.0000 |
| 12:13085242:TG:T | acceptor_gain | 1.0000 |
| 12:13085244:C:CC | acceptor_gain | 1.0000 |
| 12:13087150:A:AC | donor_gain | 1.0000 |
| 12:13087151:C:CC | donor_gain | 1.0000 |
| 12:13088794:C:A | donor_gain | 1.0000 |
| 12:13085241:ATG:A | acceptor_gain | 0.9900 |
| 12:13085243:GCTA:G | acceptor_loss | 0.9900 |
| 12:13085244:C:CA | acceptor_loss | 0.9900 |
| 12:13085245:T:C | acceptor_loss | 0.9900 |
| 12:13085254:A:AC | acceptor_gain | 0.9900 |
| 12:13085254:A:C | acceptor_gain | 0.9900 |
| 12:13087151:CT:C | donor_gain | 0.9900 |
| 12:13087151:CTA:C | donor_gain | 0.9900 |
| 12:13087151:CTAGA:C | donor_gain | 0.9900 |
| 12:13087261:GACCT:G | acceptor_loss | 0.9900 |
| 12:13087263:CCTAC:C | acceptor_loss | 0.9900 |
| 12:13087264:CTACC:C | acceptor_loss | 0.9900 |
| 12:13087265:T:A | acceptor_loss | 0.9900 |
| 12:13087900:AACTC:A | donor_loss | 0.9900 |
| 12:13087901:ACTCA:A | donor_loss | 0.9900 |
| 12:13087902:CTCA:C | donor_loss | 0.9900 |
| 12:13087903:TCAC:T | donor_loss | 0.9900 |
| 12:13087904:CA:C | donor_loss | 0.9900 |
| 12:13087905:A:C | donor_loss | 0.9900 |
| 12:13087906:C:CG | donor_loss | 0.9900 |
| 12:13088060:C:CC | acceptor_gain | 0.9900 |
| 12:13088064:C:CT | acceptor_gain | 0.9900 |
AlphaMissense
2366 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000063842 (12:13085984 C>G), RS1000869738 (12:13105310 A>G), RS1001014209 (12:13098521 A>C), RS1001142420 (12:13102045 G>C), RS1001225470 (12:13083928 CT>C), RS1001469319 (12:13102846 T>A), RS1001477195 (12:13102492 A>G), RS1001508746 (12:13098866 T>G), RS1001564253 (12:13102260 A>G), RS1002110345 (12:13097407 C>T), RS1002163892 (12:13090699 C>T), RS1002173096 (12:13096248 C>T), RS1002418698 (12:13097221 T>C), RS1002470662 (12:13100219 G>A,T), RS1002567089 (12:13100493 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005988_10 | Serum albumin levels | 1.000000e-08 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 2 |
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| butyraldehyde | increases expression | 1 |
| fipronil | affects cotreatment, decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| incobotulinumtoxinA | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| DEET | affects cotreatment, decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Particulate Matter | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.